Cutting Edge: Antitumor Immunity by Pathogen-Specific CD8 T Cells in the Absence of Cognate Antigen Recognition. Danahy DB, Berton RR, Badovinac VP. J Immunol 2020;204:1431-1435.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Danahy DB, Berton RR, Badovinac VP. Cutting Edge: Antitumor Immunity by Pathogen-Specific CD8 T Cells in the Absence of Cognate Antigen Recognition. J Immunol 2020;204:1431-1435.
PMID: 32051220